Results 261 to 270 of about 750,523 (310)
This study reveals the tumor‐suppressive role of TRIM38 in colorectal cancer (CRC). TRIM38 is downregulated through DNA hypermethylation and correlates with unfavorable clinical features and poor prognosis. Mechanistically, TRIM38 inhibits CRC progression by promoting K48‐linked ubiquitination of CCT6A, leading to the destabilization of c‐Myc.
Yue Zhang+10 more
wiley +1 more source
Regulation of Adaptive Immunity by Lipid Post-translational Modifications. [PDF]
Mattingly JR, Wu A, York AG.
europepmc +1 more source
Import of Honeybee Prepromelittin into the Endoplasmic Reticulum [PDF]
Bissel, Mina+5 more
core
This study presents a novel polyphenol‐nanozyme‐armored probiotic system (ECA@EcN) for enhanced treatment of inflammatory bowel disease (IBD). By integrating chitosan‐modified epigallocatechin gallate (EGCG‐CS) with gold nanozymes, the system effectively scavenges ROS, improves probiotic viability, and restores gut microbiota balance.
Yong Zhu+12 more
wiley +1 more source
A mini review of leveraging biobanking in the identification of novel biomarkers in neurological disorders: insights from a rapid single-cell sequencing pipeline. [PDF]
Miller JS+6 more
europepmc +1 more source
The circRNA circNAB1 is downregulated in AF patient. Silencing circNAB1 promotes collagen deposition and inflammation, whereas overexpression reduces AF susceptibility. circNAB1 encodes the protein NAB1 356 that interacts with EGR1 to mitigate fibrosis and inflammation.
William W Du+9 more
wiley +1 more source
Functions and mechanisms of non-histone post-translational modifications in cancer progression. [PDF]
Li Z+6 more
europepmc +1 more source
Tirzepatide, a dual GIP/GLP‐1 receptor agonist for diabetes, suppresses colorectal cancer growth by targeting glucose metabolism. It inhibits cancer cell proliferation, promotes apoptosis, and induces tumor regression. It reduces glucose uptake and destabilizes HIF‐1α for degradation to downregulate PFKFB3/PFK‐1 enzymes, thus contributing to the ...
Yikai Zhang+11 more
wiley +1 more source
Ribosomes: from conserved origin to functional/medical mobility and heterogeneity. [PDF]
Rivalta A+12 more
europepmc +1 more source
NRAS mutations are widespread in hematologic malignancies. Our study shows that GOLGA7 serves as a safe and effective therapeutic target for NRAS‐driven leukemia. Loss of Golga7 in adult mice effectively suppresses NrasG12D‐driven myeloproliferative neoplasm by disrupting its PM localization and impairing subsequent MAPK signaling, without affecting ...
Bo Jiao+18 more
wiley +1 more source